Pages that link to "Q44325213"
Jump to navigation
Jump to search
The following pages link to Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone (Q44325213):
Displaying 17 items.
- Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series (Q24645442) (← links)
- Effect of chronic treatment with Rosiglitazone on Leydig cell steroidogenesis in rats: in vivo and ex vivo studies (Q28575457) (← links)
- Similar causes of various reproductive disorders in early life (Q34394422) (← links)
- Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? (Q34591803) (← links)
- Thiazolidinedione use and bone loss in older diabetic adults (Q35023205) (← links)
- Glucose ingestion acutely lowers pulsatile LH and basal testosterone secretion in men. (Q35849388) (← links)
- Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome (Q35902614) (← links)
- Anterior pituitary hormone replacement therapy--a clinical review (Q36723311) (← links)
- Are the adverse effects of glitazones linked to induced testosterone deficiency? (Q36956546) (← links)
- Activation of PPARγ by Rosiglitazone does not negatively impact male sex steroid hormones in diabetic rats (Q37226962) (← links)
- The effect of thiazolidinediones on bone mineral density in Chinese older patients with type 2 diabetes (Q37551686) (← links)
- Testosterone release rate and duration of action of testosterone pellet implants (Q38479516) (← links)
- Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome (Q44823773) (← links)
- Production rates of cortisol in obesity (Q45106121) (← links)
- Effect of pioglitazone on testosterone in eugonadal men with type 2 diabetes mellitus: a randomized double-blind placebo-controlled study. (Q46161380) (← links)
- Glucagon-like peptide-1 reduces the pulsatile component of testosterone secretion in healthy males (Q46675075) (← links)
- Testosterone and insulin resistance in the metabolic syndrome and T2DM in men (Q86999417) (← links)